Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Immunosuppressive Agents pharmacology"" wg kryterium: Temat


Wyświetlanie 1-16 z 16
Tytuł :
Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy
Autorzy :
Steeples, Laura R
Spry, Paul
Lee, Richard W J
Carreño, Ester
Pokaż więcej
Temat :
Adalimumab/administration & dosage
Anti-Inflammatory Agents/administration & dosage
Chorioretinitis/complications
Drug Tolerance
Female
Fluorescein Angiography
Follow-Up Studies
Fundus Oculi
Humans
Immunosuppressive Agents/pharmacology
Intravitreal Injections
Macula Lutea/pathology
Macular Edema/diagnosis
Male
Middle Aged
Retrospective Studies
Tomography, Optical Coherence
Treatment Outcome
Visual Acuity
Journal Article
Źródło :
Steeples, L R, Spry, P, Lee, R W J & Carreño, E 2018, ' Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy ', International Ophthalmology, vol. 38, no. 3, pp. 1357-1362 . https://doi.org/10.1007/s10792-017-0592-5
Opis pliku :
application/pdf
Tytuł :
The Clinical Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis Data From a French Nationwide Study of Fifty-Seven Patients
Autorzy :
Jachiet, Marie
Flageul, Beatrice
Deroux, Alban
Le Quellec, Alain
Maurier, Francois
Cordoliani, Florence
Godmer, Pascal
Abasq, Claire
Astudillo, Leonardo
Belenotti, Pauline
Bessis, Didier
Bigot, Adrien
Doutre, Marie-Sylvie
Ebbo, Mikael
Guichard, Isabelle
Hachulla, Eric
Heron, Emmanuel
Jeudy, Geraldine
Jourde-Chiche, Noemie
Jullien, Denis
Lavigne, Christian
Machet, Laurent
Macher, Marie-Alice
Martel, Clotilde
Melboucy-Belkhir, Sara
Morice, Cecile
Petit, Antoine
Simorre, Bernard
Zenone, Thierry
Bouillet, Laurence
Bagot, Martine
Fremeaux-Bacchi, Veronique
Guillevin, Loic
Mouthon, Luc
Dupin, Nicolas
Aractingi, Selim
Terrier, Benjamin
Pokaż więcej
Temat :
Mesh:Middle Aged
Mesh:Humans
Mesh:Vasculitis/epidemiology
Mesh:Urticaria/pathology
Mesh:Skin/drug effects
Mesh:Skin/pathology
Mesh:Vasculitis/drug therapy
Mesh:Aged
Mesh:Colchicine/pharmacology
Sciences du Vivant [q-bio]
Mesh:Immunosuppressive Agents/therapeutic use
Mesh:Treatment Outcome
Mesh:Immunologic Deficiency Syndromes/epidemiology
Mesh:Urticaria/drug therapy
Mesh:Complement C1q/deficiency
Mesh:Immunologic Deficiency Syndromes/drug therapy
Mesh:Colchicine/therapeutic use
Mesh:Hydroxychloroquine/pharmacology
Mesh:Adult
Mesh:Immunosuppressive Agents/pharmacology
Mesh:80 and over
Mesh:Young Adult
Mesh:Comorbidity
Mesh:Hydroxychloroquine/therapeutic use
Mesh:Adolescent
Mesh:Vasculitis/pathology
Mesh:France/epidemiology
Mesh:Female
Mesh:Retrospective Studies
Mesh:Male
Mesh:Urticaria/epidemiology
Mesh:Immunologic Deficiency Syndromes/pathology
Tytuł :
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Autorzy :
Liu, Wei
Zi, Min
Tsui, Hoyee
Chowdhury, Sanjoy K.
Zeef, Leo
Meng, Qing Jun
Travis, Mark
Prehar, Sukhpal
Berry, Andrew
Hanley, Neil A.
Neyses, Ludwig
Xiao, Rui Ping
Oceandy, Delvac
Ke, Yunbo
Solaro, R. John
Cartwright, Elizabeth J.
Lei, Ming
Wang, Xin
Pokaż więcej
Temat :
Immunosuppressive Agents/pharmacology
periostin
Cardiology and Cardiovascular Medicine
Cell Adhesion Molecules/drug effects/physiology
Propylene Glycols/pharmacology
Fibroblasts/cytology
Mice
Mice, Inbred C57BL
Cells, Cultured
NFAT
Medicine(all)
Animals
Rats
Ventricular Pressure
Rats, Sprague-Dawley
Animals, Newborn
Cardiovascular & respiratory systems [D03] [Human health sciences]
Article
Hemodynamics/drug effects
NFATC Transcription Factors/drug effects/physiology
Cardiomegaly/drug therapy
Myocardium/pathology
Sphingosine/analogs & derivatives/pharmacology
fibrosis
cardiac hypertrophy
Male
Systèmes cardiovasculaire & respiratoire [D03] [Sciences de la santé humaine]
FTY-720
Źródło :
Circulation. Heart failure, 6(4), 833-44. United States (2013).
Liu, W, Zi, M, Tsui, H, Chowdhury, S K, Zeef, L, Meng, Q J, Travis, M, Prehar, S, Berry, A, Hanley, N, Neyses, L, Xiao, R P, Oceandy, D, Ke, Y, Solaro, R J, Cartwright, E, Lei, M & Wang, X 2013, ' A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT signaling and periostin ' Circulation: Heart Failure, vol 6, pp. 833-844 . DOI: 10.1161/CIRCHEARTFAILURE.112.000123
Liu, W, Zi, M, Tsui, H, Chowdhury, S K, Zeef, L, Meng, Q J, Travis, M, Prehar, S, Berry, A, Hanley, N A, Neyses, L, Xiao, R P, Oceandy, D, Ke, Y, Solaro, R J, Cartwright, E J, Lei, M & Wang, X 2013, ' A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin ', Circulation: Heart Failure, vol. 6, no. 4, pp. 833-844 . https://doi.org/10.1161/CIRCHEARTFAILURE.112.000123, https://doi.org/10.1161/CIRCHEARTFAILURE.112.000123
Opis pliku :
application/octet-stream
Tytuł :
Dominant-Negative Tumor Necrosis Factor Protects from Mycobacterium bovis Bacillus Calmette-Guérin (BCG) and Endotoxin-Induced Liver Injury without Compromising Host Immunity to BCG and Mycobacterium tuberculosis
Autorzy :
Olleros, Maria-Luisa
Vesin, Marie-Dominique
Fotio Lambou, Agathe
Janssens, Jean-Paul
Ryffel, Bernhard
Rose, Stéphanie
Frémond, Cécile
Quesniaux, Valérie F
Szymkowski, David E
Garcia, Irène
Pokaż więcej
Temat :
Drug-Induced Liver Injury
MESH: Animals
Mycobacterium tuberculosis/immunology
MESH: Lipopolysaccharides
Immunosuppressive Agents/pharmacology
MESH: Tuberculosis
Receptors, Tumor Necrosis Factor
[SDV.IMM]Life Sciences [q-bio]/Immunology
MESH: Mycobacterium tuberculosis
MESH: Tumor Necrosis Factor-alpha
Mice
Mice, Knockout
Mice, Inbred C57BL
MESH: Liver Diseases
MESH: Mice, Inbred C57BL
Animals
MESH: Immunoglobulin G
Cell Line
MESH: Cell Line
Tumor Necrosis Factor-alpha/antagonists & inhibitors/pharmacology/physiology
MESH: Immunosuppressive Agents
ddc:616
MESH: Receptors, Tumor Necrosis Factor
ddc:616.07
Liver Diseases/prevention & control
Immunoglobulin G/pharmacology
MESH: Mice
Lung/pathology
MESH: Lung
MESH: Mice, Knockout
Tuberculosis/immunology/pathology
Mycobacterium bovis/immunology
Lipopolysaccharides/toxicity
MESH: Mycobacterium bovis
Źródło :
The Journal of Infectious Diseases, Vol. 199, No 7 (2009) pp. 1053-63
Journal of Infectious Diseases
Journal of Infectious Diseases, Oxford University Press (OUP), 2009, 199 (7), pp.1053-63. ⟨10.1086/597204⟩
Tytuł :
Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin
Autorzy :
Hoogduijn, Martin J
Crop, Meindert J
Korevaar, Sander S
Peeters, Annemiek M A
Eijken, Marco
Maat, Lex P W M
Balk, Aggie H M M
Weimar, Willem
Baan, Carla C
Pokaż więcej
Temat :
Apoptosis/drug effects
Cell Differentiation/drug effects
Cell Proliferation/drug effects
Cell Survival/drug effects
Cells, Cultured
Dose-Response Relationship, Drug
Enzyme Inhibitors/pharmacology
Humans
Immunosuppression
Immunosuppressive Agents/pharmacology
Mesenchymal Stem Cells/cytology
Mycophenolic Acid/pharmacology
Sirolimus/pharmacology
Tacrolimus/pharmacology
Time Factors
Źródło :
Hoogduijn, M J, Crop, M J, Korevaar, S S, Peeters, A M A, Eijken, M, Maat, L P W M, Balk, A H M M, Weimar, W & Baan, C C 2008, ' Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin ', Transplantation, vol. 86, no. 9, pp. 1283-91 . https://doi.org/10.1097/TP.0b013e31818aa536
    Wyświetlanie 1-16 z 16

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies